Apollo Biowellness, Inc., Corporate Status and Merger Update

Core Insights - Apollo Biowellness, Inc. is updating shareholders on corporate developments and the merger with Revive Regenerative, Inc. [1] - The merger's original closing date was October 30, 2025, but an extension of approximately 30 days is needed to complete the process [1] - The company is negotiating to convert all debt to equity as a condition for closing the merger [1] Corporate Developments - The company has completed initial bridge financing of $500,000 for the merger and is seeking an additional $3,000,000 as per the Merger Agreement [1] - A definitive update on the debt conversion is expected within the next 7 to 10 days [1] - The company is also negotiating with a tele-med GPL-1 Peptide company to expand its product offerings [1] Product and Market Positioning - The merger aims to create a fully integrated company combining laser and energy devices with exosome-based biologic aesthetic products and GLP-1 weight loss products [3] - This integration is expected to significantly increase top-line revenues and enhance EBITDA [3] - Apollo Biowellness is positioning itself as a leader in Regenerative Medicine, focusing on biologic-based products [4]